About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Endothelial Cell Loss After Cataract Surgery

NCT00932191·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

University of California, San Francisco

Age

40–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Visually significant moderate density cataract

You may not be if

Corneal or retinal pathology limiting visual potential to worse than 20/40
Lens pathology including pseudoexfoliation or lens dislocation
Prior intraocular surgery
Age less than 40

The record

StatusTerminated

PhasePhase 2–3

Taking part39

StartedJul 2009

UpdatedAug 25, 2014

Conditions

Where1

University of California San Francisco
San Francisco, California, United States

Clareo Health | Endothelial Cell Loss After Cataract Surgery